Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health – Europe
Stephanie Becker, Senior Editor at The Lancet Regional Health – Europe, shared on LinkedIn:
”Exciting advances in stroke research were front and centre at ESOC 2026 in Maastricht, where more than 4000 delegates from 96 countries gathered to discuss the future of stroke prevention, intervention, and recovery.
Our conference highlights are now live in The Lancet Regional Health – Europe.
I was delighted to attend this conference held by the European Stroke Organisation, meeting enthusiastic and driven researchers and hearing about the latest research in the field that could help shape the next generation of stroke care.
Some standout findings included:
- The HOPE trial, showing that personalised blood pressure targets after thrombectomy may significantly improve functional recovery after acute ischaemic stroke.
- New OCEANIC-STROKE analyses suggesting that asundexian not only reduces recurrent stroke risk, but may also lessen stroke severity and disability.
- The DISTALS trial, demonstrating promising results for a novel low-profile stent-retriever designed specifically for distal vessel occlusions.
- ATILA trial findings showing that low-dose tirofiban reduced acute in-stent thrombosis by more than half following thrombectomy and carotid stenting.
- The ATLAS meta-analysis, providing compelling evidence that patients with large-core ischaemic stroke can still benefit from endovascular thrombectomy — challenging long-standing assumptions in the field.
What stood out most at this year’s meeting was the momentum across stroke research: from refining thrombectomy strategies to improving secondary prevention and expanding treatment eligibility for patients previously thought unlikely to benefit.
A fascinating and energising few days for everyone working in cerebrovascular medicine.
Read my full conference highlights.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders